Vaxxinity

IPO

Public · Dallas, United States · Founded 2021 · $14.2M raised

Headquarters
Dallas, Texas
Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$14.2M
Last Round
$9.3M GrantApr 2022
Rounds
3
Type
Public

About

Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health, with a focus on developing peptide-based therapeutic vaccines for chronic diseases including Alzheimer's, Parkinson's, and COVID-19. Formed in 2021 through the combination of COVAXX and United Neuroscience, the company is headquartered in Dallas, Texas, and uses an immune-system-based approach to deliver vaccines that are cost-effective, long-lasting, and effective against emerging variants without requiring cold-chain mRNA technology. Vaxxinity's mission is to make high-quality biologic medicines accessible to people around the world by replacing expensive injectable biologics with affordable vaccine alternatives.

Summary

Vaxxinity is a Biotech company based in Dallas, United States, founded in 2021. It has raised $14.2M in total across 3 rounds, most recently a $9.3M Grant round in Apr 2022. Investors include CEPI, BofA Securities and Jefferies.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantApr 2022
$9.3M

Sign up to see all 4 rounds

Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vaxxinity on Indexed.vc
<a href="https://indexed.vc/companies/vaxxinity"><img src="https://indexed.vc/api/badge/company/vaxxinity" alt="Vaxxinity on Indexed.vc" width="260" height="76" /></a>